🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BNT
$BNTX
🔒 US EquitiesBioNTech SE
AVG HISTORICAL GAP
-2.79%
MAX GAP RECORD
-18.94%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BNTX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BNTX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN) |
-3.54%
|
| May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN) |
-3.60%
|
| Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN) |
-18.94%
|
| Nov 03, 2025 Earnings Release 2025-11-03 (BEFORE OPEN) |
+0.86%
|
| Aug 04, 2025 Earnings Release 2025-08-04 (BEFORE OPEN) |
+4.71%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-0.29%
|
| Mar 10, 2025 Earnings Release 2025-03-10 (BEFORE OPEN) |
-2.77%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (2)
Bearish Gaps (8)
Neutral / Flat (4)
📖 Intelligence Summary
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗